NEWS & MEDIA

JPM CBRN Medical publication featured in the Journal of Pharmacology and Experimental Therapeutics
October 12, 2023 — JPM CBRN Medical published "Strengthening Warfighter Resiliency Using Broad-Spectrum or Host-Directed Therapies within the Rapid Acquisition and Investigation of Drugs for Repurposing (RAIDR) Program" in the Journal of Pharmacology and Experimental Therapeutics. Learn more about the article and the team's work on the RAIDR program...

AL&T Feature - Fail Forward and Pivot
October 2, 2023 — JPM CBRN Medical, BARDA and UTMB personnel during a UTMB site visit. (Photo by Sarah Murtaza, BARDA) Read the full article about the JPM CBRN Medical's VAMP program that takes an agile approach to accelerate the delivery of vaccines against priority threats - https://asc.army.mil/web/news-fail-forward-and-pivot/

Courage, Commitment, and COVID-19: How the JA2 Team Achieved Success in the Face of a Global Pandemic
September 29, 2023 — "In the face of an unprecedented challenge, the JA2 team united government agencies, contractors, academia and industry experts to rewrite the script of our battle against COVID-19." – Mr. Darryl J. Colvin, Joint Program Executive Officer for Chemical, Biological, Radiological and Nuclear Defense (CBRN). The U.S. held its collective breath this...

DOD Announces Release of 2023 Strategy for Countering Weapons of Mass Destruction
September 28, 2023 — Today, the Department of Defense released the unclassified version of its 2023 Strategy for Countering Weapons of Mass Destruction (CWMD). The 2023 DOD CWMD Strategy seeks to account for current and emerging WMD challenges and threats, and provide tailored methods to address them. The Department will account for WMD threats holistically to prevent,...

ASC Faces of the Force - Public Service Above All
September 27, 2023 — Read the full article featuring JPEO-CBRND's JPM CBRN Medical staff member Wai Kwan Chung - https://asc.army.mil/web/news-public-service-above-all/

Army AL&T Feature - Expedited Delivery
September 18, 2023 — The naloxone autoinjector is a rescue treatment that will counteract the adverse effects from exposure to opioids and allows impacted service members to remain ambulatory to move to higher levels of care. (Photo provided courtesy of Kaléo, Inc.) Read the full article about how the JPEO-CBRND filled a gap in Europe with rapid delivery of a...

Phage Selected, Nature Approved: A Biothreat Detection Paradigm
September 15, 2023 — When the Defense Department (DOD) needs to develop tools and equipment to protect the Joint Force, it is critical that these items are put through rigorous testing and validation measures to ensure that they have the proper capabilities to beat the evolving threat. The Defense Biological Product Assurance Office (DBPAO), which is a part of the...

Safety Day 2023: Taking Personal Responsibility for a Safer Tomorrow
September 7, 2023 — On August 31, 2023, the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) hosted Safety Day. The event served as a reminder of the paramount importance of safety inside and out of the workplace. Mr. Darryl Colvin, the Joint Program Executive Officer for CBRN Defense, emphasized in his opening...

Enhancing Safety and Efficiency: DOD’s Radiological Detection System
August 31, 2023 — A groundbreaking technology that supports the Defense Department’s (DOD) commitment to safeguarding our forces is the Radiological Detection System (RDS). Replacing the current radiation detection, indication and computation (RADIAC) system, the RDS consolidates capabilities across the Joint Force. The RDS represents a transformative response to a...

DOD-Supported Lifesaving Autoinjector to Combat Ultra-Potent Opioid Exposure Available through DLA
August 23, 2023 — Long approved for pain control in civilian and military medicine, synthetic opioids are substances that are created in a laboratory and act on the same targets in the brain as natural opiates like morphine and codeine. However, while developed with the best of intentions for pain relief, synthetic opioids such as fentanyl and carfentanil are also...

News Search

News Archive - Search by Year and Month

2026 (14)
2025 (19)
2024 (40)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
2019 (11)
2018 (5)
2017 (9)
2016 (1)

CPE CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the CPE CBRND's Capabilities Catalog, Leadership Biographies, and contracting overview documents.

CPE CBRND Public Affairs Office

The CPE CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the CPE CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.

The information contained in these articles has been reviewed and approved for public release.

The appearance of hyperlinks does not constitute endorsement by the CPE CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the CPE CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.